About Infinimmune
Infinimmune develops human-derived antibody medicines using B-cell sequencing, computational modeling, and antibody engineering technology.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Alameda, United States
Tracked Since
Sep 28, 2026
Web & Domain Identity
Official Website
infinimmune.com
Domain Registered Date
Sep 23, 2021
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Milestone
X account created (@infinimmune)
139 followers
- Milestone
Website domain registered
infinimmune.com
Investors & Backers
Civilization Ventures
Everbright Biofund
Forge Life Science Partners
Godfrey Capital
Goldcrest Capital
Merck Global Health Innovation Fund
Pear VC
Playground Global
Regeneron Ventures
Wild Tree Ventures
Funding History
Venture Round
· Undisclosed
Undisclosed Source
Founders & Leadership
Anthony Slavin
Senior Vice President of Portfolio Strategy
Work email & phone locked
Unlock →
David Jaffe
Infinimmune Fellow & Co-Founder
Work email & phone locked
Unlock →
Katie Pfeiffer
Chief Technology Officer & Co-Founder
Work email & phone locked
Unlock →
Lance Hepler
Chief Information Officer & Co-Founder
Work email & phone locked
Unlock →
Mike Gibbons
Chief Scientific Officer & Co-Founder
Work email & phone locked
Unlock →
Srikanth Pendyala
Chief Medical Officer
Work email & phone locked
Unlock →
Tim Sullivan
CBO
Work email & phone locked
Unlock →
Wyatt McDonnell
CEO & Co-Founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026